Skip to main content
TrimSoMoEverything GLP-1, in one place
Financial Modeling Tool

GLP-1 Out-of-Pocket & Savings Card Calculator

Independent expense modeling based on verified 2026 manufacturer terms.

Select your medication and health insurance status to see realistic monthly co-pays, manufacturer savings card eligibility, deductible impacts, and prior authorization advice.

Interactive Decision Tool

GLP-1 Insurance & Savings Card Cost Estimator

Estimate your realistic out-of-pocket monthly expense and determine manufacturer copay card eligibility rules.

Prior Authorization Guide →

Selected: Wegovy (Semaglutide weekly injection). List price before insurance or coupons: ~$1,349 / 28-day supply.

Estimated Monthly Out-of-Pocket
$25 – $150 / month
Fully Eligible for Savings Card

Your commercial insurance plan covers anti-obesity medications on its formulary.

  • Manufacturer copay cards from Novo Nordisk typically reduce out-of-pocket costs to as low as $25/month for up to 12 or 24 months.
  • Maximum manufacturer benefit caps generally range from $150 to $225 per month ($1,800 to $2,100 per calendar year).
  • Subject to pharmacy benefit manager (PBM) tier placement and your plan deductible requirements.
Prescriber Action Plan: Ask your prescribing doctor to submit a comprehensive Prior Authorization (PA) packet confirming BMI qualification and comorbidity documentation to satisfy plan coverage rules.

PA requirement notes: Approval typically requires documented BMI ≥30 or BMI ≥27 with at least one metabolic comorbidity, plus notes on prior lifestyle intervention attempts.

Need a prescriber to file a Prior Authorization?

Transparency & Compliance Notice: Out-of-pocket estimates are educational benchmarks reflecting published manufacturer coupon guidelines, wholesale acquisition cost benchmarks, and commercial health plan rules as of 2026. TrimSoMo is an independent, non-commercial informational directory and has no financial affiliation with Novo Nordisk, Eli Lilly, or pharmacy benefit managers (PBMs). Final copays are determined solely by your employer contract, insurer deductible, and dispensing pharmacy.

1. How Manufacturer Copay Assistance Cards Actually Work

Both Eli Lilly (maker of Zepbound) and Novo Nordisk (maker of Wegovy and Saxenda) provide commercial copay cards designed to reduce out-of-pocket friction for patients. However, how much you actually pay depends entirely on whether your health plan covers the drug on its formulary:

Scenario A: Insurance Covers the Drug

As Low as $25 / Month

If your commercial health plan includes anti-obesity medications on its formulary and approves your Prior Authorization (PA), the card acts as secondary insurance. It pays up to $150–$225 of your remaining copay each month, subject to annual program maximums ($1,800–$2,100 per calendar year).

Scenario B: Insurance Excludes Weight Loss

$550 – $650 / Month

If your employer has explicitly excluded weight management medications from your benefit design, the card provides a partial subsidy off the full list price (~$1,060 to $1,349/month). While substantially discounted, you must still budget $550+ monthly out-of-pocket.

2. The Federal Healthcare Ban (Medicare, Medicaid & TRICARE)

One of the most confusing aspects of GLP-1 pricing is why patients with government insurance cannot use manufacturer copay coupons:

  • The Anti-Kickback Statute (42 U.S.C. § 1320a-7b): Federal law prohibits drug manufacturers from offering financial inducements or discounts to individuals enrolled in federal healthcare programs. Violating this rule carries severe criminal and civil penalties.
  • Medicare Part D Statutory Weight Loss Exclusion: Section 1860D-2(e)(2)(A) of the Social Security Act excludes medications used for anorexia, weight loss, or weight gain from standard Part D benefit design.
  • The Cardiovascular Exception (CMS 2024 Memo): CMS allows Part D plans to cover Wegovy exclusively for patients with established cardiovascular disease (prior stroke, heart attack, or peripheral artery disease) to prevent adverse cardiac events, but not for standalone weight loss.

3. High-Deductible Health Plans (HDHP) & Copay Accumulator Pitfalls

If you are enrolled in an HSA-eligible High-Deductible Health Plan, your pharmacy benefits often share an integrated deductible with medical services. This creates two distinct challenges:

The January Deductible Reset

Before you satisfy your annual deductible (often $1,650 to $3,300+), your insurance pays $0 toward prescription fills. If you use a copay card, it will absorb the first $150–$225, but you must pay the remaining balance in cash until your deductible is cleared.

Copay Accumulator Programs

Some PBMs (Express Scripts, Caremark, OptumRx) employ copay accumulators that prevent manufacturer coupon dollars from counting toward your annual deductible. Always contact your member services representative to inquire: “Does manufacturer assistance count toward my true out-of-pocket maximum?”

4. Prior Authorization (PA) Denial Appeal Strategy

Over 60% of initial GLP-1 Prior Authorization requests are initially rejected for documentation omissions rather than medical disqualification. Here is the 3-step appeal pathway:

1

Request the Denial Reason Code

Obtain the specific denial letter from your PBM to determine whether the claim was denied for missing lifestyle trial documentation or true non-formulary exclusion.

2

Attach 6-Month Chart Notes

Have your prescriber supply clinical chart notes proving prior participation in comprehensive lifestyle interventions (dietary logs, exercise, or generic pharmacotherapy).

3

Schedule Peer-to-Peer Review

A 10-minute physician-to-medical-director telephone review resolves approximately 40% of contested prior authorization denials.

Cost & Coverage Questions

Frequently Asked Questions About GLP-1 Costs

How does a manufacturer savings card work at the pharmacy?↓

When you take your prescription to the pharmacy, your primary commercial insurance is billed first. The pharmacy then submits the copay balance to the manufacturer savings card (administered as secondary insurance with BIN, PCN, and Group numbers). The savings program absorbs a portion of your remaining copay—bringing costs down to as low as $25 per month for covered commercial plans.

Why can’t I use a copay coupon if I have Medicare Part D?↓

Under the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b), pharmaceutical companies are legally prohibited from offering copay assistance cards, discounts, or coupons to anyone covered by federal or state healthcare programs, including Medicare, Medicaid, Medigap, DoD TRICARE, or the VA.

Does Medicare cover GLP-1 medications for any condition?↓

Under the Medicare Modernization Act of 2003, Medicare Part D plans are statutory prohibited from covering medications prescribed solely for weight loss. However, CMS issued guidance allowing Part D plans to cover semaglutide (Wegovy) for individuals with established cardiovascular disease (prior heart attack, stroke) to reduce cardiovascular death risk.

What is a copay accumulator program, and how does it affect me?↓

A copay accumulator adjuster program is a health insurance policy where the insurer accepts the manufacturer savings card benefit to pay your copay at the pharmacy counter, but does NOT count the manufacturer subsidy toward your annual deductible or out-of-pocket maximum. Once the manufacturer savings cap is exhausted, you may abruptly face the full retail price until your deductible is met.

What should I do if my commercial insurance completely denies coverage?↓

First, obtain the formal Denial of Benefits letter to determine the denial reason code (e.g., plan exclusion vs. missing Prior Authorization clinical documentation). If your plan has a strict anti-obesity exclusion, ask your prescriber about Eli Lilly’s direct self-pay vial options ($399–$549/mo for Zepbound 2.5mg/5mg vials via LillyDirect) or explore manufacturer uncovered savings card discounts.

Next Decision Steps

Prepare for Your Clinician Consultation

Now that you understand the financial landscape, generate your personalized 12-point clinical lab and questions checklist.